Project Details
Description
Canberra Clinical Phenomics (CCP) will establish a nationally unique and internationally leading capacity for integration and delivery of accredited genomic and in-depth blood and protein (phenomic) diagnostics for the delivery of precision medicines (PMs). CCP will provide new diagnostic/phenomics tools to overcome translational hurdles that prevent progress in patient treatment. CCP will support clinicians to evaluate novel treatment for patients, clinical trials and rapid response to pandemics.
| Status | Finished |
|---|---|
| Effective start/end date | 1/07/22 → 30/06/24 |
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.